Related Experiment Video
Updated: Apr 18, 2026
08:55
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
13.0K
Platelets: the next-generation ovarian cancer biomarker?
Amelia Janiak1, Vahid Afshar-Kharghan2, David G Menter3
1Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Trends in Cancer
|April 16, 2026
Summary
Ovarian cancer diagnosis is challenging. Platelets may offer new biomarkers for detecting and monitoring this cancer due to their connection to tumor activity.
Area of Science:
- Oncology
- Hematology
- Biomarker Discovery
Background:
- Ovarian cancer diagnosis and monitoring face significant hurdles, including vague symptoms and late detection.
- High recurrence rates further complicate patient management.
- Circulating platelets are increasingly recognized for their potential to reflect tumor presence and activity.
Purpose of the Study:
- To explore the potential of platelet-based signatures as novel biomarkers for ovarian cancer.
- To investigate if molecular and functional platelet characteristics can aid in ovarian cancer diagnosis and monitoring.
Main Methods:
- Analysis of circulating platelets in ovarian cancer patients.
- Identification of specific molecular and functional signatures in platelets.
Main Results:
- Evidence suggests a correlation between platelet profiles and ovarian cancer presence.
- Platelet signatures show promise in reflecting tumor activity.
Conclusions:
- Platelet-based biomarkers represent a promising avenue for improving ovarian cancer diagnosis and monitoring.
- Further research into platelet signatures could lead to new clinical tools for ovarian cancer management.
